BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 24677249)

  • 1. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
    Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
    Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
    Wang YD; Wu LL; Mai YN; Wang K; Tang Y; Wang QY; Li JY; Jiang LY; Liao ZZ; Hu C; Wang YY; Liu JJ; Liu JH; Xiao XH
    Metabolism; 2023 Sep; 146():155660. PubMed ID: 37451670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
    Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1.
    Meng X; Guo J; Fang W; Dou L; Li M; Huang X; Zhou S; Man Y; Tang W; Yu L; Li J
    J Biol Chem; 2016 May; 291(20):10625-34. PubMed ID: 27013659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
    Zhang T; Zhao X; Steer CJ; Yan G; Song G
    Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis.
    Zhong H; Chen K; Feng M; Shao W; Wu J; Chen K; Liang T; Liu C
    FEBS J; 2018 Feb; 285(3):501-517. PubMed ID: 29197188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression.
    Zhang T; Duan J; Zhang L; Li Z; Steer CJ; Yan G; Song G
    Hepatology; 2019 Apr; 69(4):1488-1503. PubMed ID: 30281809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-27b Depletion Enhances Endotrophic and Intravascular Lipid Accumulation and Induces Adipocyte Hyperplasia in Zebrafish.
    Hsu CC; Lai CY; Lin CY; Yeh KY; Her GM
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
    Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
    Wu H; Ng R; Chen X; Steer CJ; Song G
    Gut; 2016 Nov; 65(11):1850-1860. PubMed ID: 26282675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
    Wang XY; Lu LJ; Li YM; Xu CF
    Life Sci; 2022 Nov; 308():120925. PubMed ID: 36057399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
    Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
    World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
    Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
    Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression.
    Azzu V; Vacca M; Kamzolas I; Hall Z; Leslie J; Carobbio S; Virtue S; Davies SE; Lukasik A; Dale M; Bohlooly-Y M; Acharjee A; Lindén D; Bidault G; Petsalaki E; Griffin JL; Oakley F; Allison MED; Vidal-Puig A
    Mol Metab; 2021 Jun; 48():101210. PubMed ID: 33722690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
    Zhang M; Sun W; Zhou M; Tang Y
    Sci Rep; 2017 Nov; 7(1):14493. PubMed ID: 29101357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes.
    Latorre J; Ortega FJ; Liñares-Pose L; Moreno-Navarrete JM; Lluch A; Comas F; Oliveras-Cañellas N; Ricart W; Höring M; Zhou Y; Liebisch G; Nidhina Haridas PA; Olkkonen VM; López M; Fernández-Real JM
    EBioMedicine; 2020 Mar; 53():102697. PubMed ID: 32143184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.